Make an enquiry

Rachel Havard

Partner

A.A. Thornton & Co

Rachel Havard is a Partner and Chartered Trade Mark Attorney. Rachel handles a wide range of UK and international trade mark cases. Her portfolio of clients covers a variety of sectors, including fashion retail, automotives, medical devices and pharmaceuticals.

Services

  • Copyright
  • Design Rights
  • Domain Names
  • Trade Marks
  • IP Due Diligence & Freedom to Operate
  • IP Strategy & Audits
  • IP Transactions, Ownership & Licensing
  • Anti-Counterfeiting

Core Responsibilities

  • Clearing of Trade Marks for use and/or registration
  • Advising on appropriate systems for trade mark registration in the UK and worldwide, and pursuing such protection
  • Advising on trade mark enforcement
  • Drafting of co-existence agreements and negotiating amicable settlements
  • Advice upon assignments and changes of ownership and recordal of same
  • Part of the Marketing Committee

Career

  • Rachel began her career in 1995 at Hepworth Lawrence Bryer & Bizley, Patent & Trade Mark Attorneys
  • She joined AA Thornton in 1999
  • She became a partner in 2006

Industries

  • Automotive & Aerospace
  • Electronics & Electrical Engineering
  • Medical Devices
  • Pharmaceuticals
  • Retail

Qualifications

  • LLB Hons Law, University of Glamorgan
  • UK Chartered Trade Mark Attorney
  • European Trade Mark and Designs Attorney

Professional Memberships

  • Chartered Institute of Trade Mark Attorneys (CITMA)
  • International Trademark Association (INTA)
  • Pharmaceutical Trade Marks Group (PTMG)

Awards / Accolades

  • Recommended in Legal 500 UK – “Rachel Havard is also recommended for her handling of a wide range of UK and international trade mark cases”
  • Ranked in the Managing Intellectual Property IP Stars 2018

Related News

AA Thornton ranked with ‘Leading Firm’ status in the Legal 500 2019

  The Legal 500 2019 edition has now been published and we are delighted that the firm has once again been ranked as a leading firm for both patents and trade marks, and that our level of service was recognised, once again, as “outstanding”:  “The ‘excellent’ A.A. Thornton & Co. ‘goes the extra mile to provide outstanding customer service’ and has… Read more »

UPDATE: 27 September 2018 – Brexit: EU Trade Marks and Community Designs, including if there is ‘no deal’

Brexit: EU Trade Marks and Community Designs, including if there is ‘no deal’   What is the current situation? The UK is to leave the EU (“Brexit”) on 29 March 2019.  When Brexit becomes fully effective, EU unitary trade mark registrations (“EUTMs”) and registered Community designs (“RCDs”) will cease to have effect in the UK,… Read more »

European Union Trade Marks and Community Designs, post-Brexit

The UK is to leave the EU (“Brexit”) in March 2019, but a transitional (“implementation”) period is expected to apply until at least 31 December 2020, in which existing IP rights obtained under EU law and therefore affected by Brexit will continue to have effect in the UK. When Brexit becomes fully effective, EU unitary… Read more »

Related Events

  • PTMG Spring Conference

    Trade Mark Partner Rachel Havard and Consulting Patent Attorney Julie Barrett Major will represent the firm at the Spring Pharmaceutical Trade Marks Group conference in Porto, Portugal from 18th – 20th March. PTMG is a not for profit organisation and their primary objective is to enable members to meet at regular intervals to consider problems… Read more »

Related Publications

  • Brexit update – December 2018

    EU Trade Marks and Community Designs – Deal, no deal, or no Brexit at all?   What is the current situation? Considerable doubt remains about how, when or even if the UK will leave the EU.  However, if the UK leaves without a deal then the outcome in relation to IP should be essentially the… Read more »

  • J. Choo Limited v Liangliang Ren

    “If your hair is done properly and you’re wearing good shoes, you can get away with anything.” – Iris Apfel   Introduction Not according to the EUIPO in the recent decision in Opposition No. B002757717 of J. Choo Limited v Liangliang Ren, when the Opposition Division handed down a decision to reject the mark:  … Read more »

  • EU: Falsified Medicines Directive: Implications for parallel importers and of Brexit

    EU: Falsified Medicines Directive: Implications for parallel importers and of Brexit This article was updated: 8 October 2018   Introduction to the Falsified Medicines Directive Directive 2011/62/EU, better known as “The Falsified Medicines Directive” or “FMD”, came into force on 2 January 2013, with the aim of preventing falsified medicines from entering the legitimate supply… Read more »